Market Place
Sourcing Support
IONTAS Collaboration With F-star Enters Oncology Phase 1 Clinical Trial
29 Jun 2021 //
BUSINESSWIRE
IONTAS Identifies Novel SARS-CoV-2 Neutralising Antibodies
22 Mar 2021 //
BUSINESSWIRE
IONTAS Identifies Novel SARS-CoV-2 Neutralising Antibodies
22 Mar 2021 //
BUSINESSWIRE
IONTAS and FairJourney Biologics Enter Antibody Discovery Agreement With Quell
08 Mar 2021 //
BUSINESSWIRE
Iontas Enters Licensing Agreement with Bristol Myers Squibb
15 Oct 2020 //
CONTRACTPHARMA
IONTAS Announces a New Collaboration to Identify Novel Immunotherapy Targets
07 May 2020 //
BUSINESSWIRE
Leading Global Antibody Discovery FairJourney Biologics & Iontas SARS-CoV-2
16 Apr 2020 //
BUSINESSWIRE
IONTAS, Adaptate Enter Antibodies Alliance
03 Dec 2019 //
PRESS RELEASE
IONTAS Announces New Antibody Optimisation Agreement With Teva Pharmaceuticals
29 Jul 2019 //
BUSINESSWIRE
IONTAS Celebrates 5 Years of Antibody Discovery
02 Jul 2018 //
BUSINESSWIRE
Iontas gets UK backing for chronic pain antibody project
01 Jun 2018 //
PM LIVE
IONTAS Awarded £556K ($737K) from Innovate UK to Develop Therapies for CPM
30 May 2018 //
BUSINESSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.